CVS Caremark Reshapes Weight Loss Drug Coverage in 2025: Zepbound Out, Wegovy In

By Andrew Hewitt A big pharmacy benefit manager (PBM), CVS Caremark, has made big changes to how it covers GLP-1 drugs, especially those used for weight loss, as of July 1, 2025. In particular:CVS Caremark has stopped covering Zepbound, an Eli Lilly GLP-1 drug that is approved for long-term weight control. Why did they make […]